4Filing Date: Apr 29, 2026

Abbott (ABT)

Statement of Changes in Beneficial Ownership

View SEC Filing
ACC: 0001783147-26-000009
Total Value$501.7K
Trades2
Insiders1

Transaction Details

Moreland Mary K
EXECUTIVE VICE PRESIDENT·Indirect · Profit Sharing Trust
Discretionary · Acquire
Common shares without par value
Shares+5.31K
Price$94.41
Total Value$501.7K
Shares Owned After17.16K
Transaction DateApr 28, 2026
Footnotes ▸

Balance in the Abbott Laboratories Stock Retirement Trust as of April 28, 2026.

Moreland Mary K
EXECUTIVE VICE PRESIDENT·Direct
Common shares without par value
Shares0
Price-
Total Value$0
Shares Owned After104.29K

Post-Transaction Holdings

Moreland Mary K · EXECUTIVE VICE PRESIDENT
SecuritySharesChange
Common shares without par value121.45K+5.31K (4.58%)
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-04-28 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: ABBOTT LABORATORIES (ABT) CIK: 0000001800 --- Reporting Owner --- Name: Moreland Mary K CIK: 0001783147 Role: Officer (EXECUTIVE VICE PRESIDENT) --- Non-Derivative Transactions --- [Transaction #1] Security: Common shares without par value Date: 2026-04-28 | Code: I (Discretionary (intra-plan)) Shares: +5,314 | Price: $94.41 Total Value: $501,694.74 Shares Owned After: 17,159 | Ownership: I (Indirect) | Nature: Profit Sharing Trust Footnotes: [F1] Balance in the Abbott Laboratories Stock Retirement Trust as of April 28, 2026. --- Holdings --- [Holding #1] Security: Common shares without par value Ownership: D (Direct) --- Footnotes (Complete Index) --- F1: Balance in the Abbott Laboratories Stock Retirement Trust as of April 28, 2026. --- Signature --- /s/ /s/ Mary K. Moreland by Jessica H. Paik, Attorney-in-Fact (2026-04-29)

keid analysis is for reference only and does not constitute investment advice.